• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎疾病活动度、功能受限进展与骨科手术长期风险之间的关联:两项前瞻性队列的联合分析支持欧洲抗风湿病联盟(EULAR)的治疗达标疾病活动度评分(DAS)阈值。

Association between rheumatoid arthritis disease activity, progression of functional limitation and long-term risk of orthopaedic surgery: combined analysis of two prospective cohorts supports EULAR treat to target DAS thresholds.

作者信息

Nikiphorou Elena, Norton Sam, Young Adam, Carpenter Lewis, Dixey Josh, Walsh David Andrew, Kiely Patrick

机构信息

Department of Rheumatology, Whittington Hospital NHS Trust, London, UK.

Early Rheumatoid Arthritis Study, Department of Rheumatology, St Albans City Hospital, St Albans, UK.

出版信息

Ann Rheum Dis. 2016 Dec;75(12):2080-2086. doi: 10.1136/annrheumdis-2015-208669. Epub 2016 Mar 15.

DOI:10.1136/annrheumdis-2015-208669
PMID:26979104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5136699/
Abstract

OBJECTIVES

To examine the association between disease activity in early rheumatoid arthritis (RA), functional limitation and long-term orthopaedic episodes.

METHODS

Health Assessment Questionnaire (HAQ) disability scores were collected from two longitudinal early RA inception cohorts in routine care; Early Rheumatoid Arthritis Study and Early Rheumatoid Arthritis Network from 1986 to 2012. The incidence of major and intermediate orthopaedic surgical episodes over 25 years was collected from national data sets. Disease activity was categorised by mean disease activity score (DAS28) annually between years 1 and 5; remission (RDAS≤2.6), low (LDAS>2.6-3.2), low-moderate (LMDAS≥3.2-4.19), high-moderate (HMDAS 4.2-5.1) and high (HDAS>5.1).

RESULTS

Data from 2045 patients were analysed. Patients in RDAS showed no HAQ progression over 5 years, whereas there was a significant relationship between rising DAS28 category and HAQ at 1 year, and the rate of HAQ progression between years 1 and 5. During 27 986 person-years follow-up, 392 intermediate and 591 major surgeries were observed. Compared with the RDAS category, there was a significantly increased cumulative incidence of intermediate surgery in HDAS (OR 2.59 CI 1.49 to 4.52) and HMDAS (OR 1.8 CI 1.05 to 3.11) categories, and for major surgery in HDAS (OR 2.48 CI 1.5 to 4.11), HMDAS (OR 2.16 CI 1.32 to 3.52) and LMDAS (OR 2.07 CI 1.28 to 3.33) categories. There was no significant difference in HAQ progression or orthopaedic episodes between RDAS and LDAS categories.

CONCLUSIONS

There is an association between disease activity and both poor function and long-term orthopaedic episodes. This illustrates the far from benign consequences of persistent moderate disease activity, and supports European League Against Rheumatism treat to target recommendations to secure low disease activity or remission in all patients.

摘要

目的

研究早期类风湿关节炎(RA)的疾病活动度、功能受限与长期骨科事件之间的关联。

方法

从两个常规护理中的早期RA起始队列收集健康评估问卷(HAQ)残疾评分;1986年至2012年的早期类风湿关节炎研究和早期类风湿关节炎网络。从国家数据集收集25年期间主要和中级骨科手术事件的发生率。在第1年至第5年期间,每年根据平均疾病活动评分(DAS28)对疾病活动度进行分类;缓解(DAS≤2.6)、低度(DAS>2.6 - 3.2)、低中度(DAS≥3.2 - 4.19)、高中度(DAS 4.2 - 5.1)和高度(DAS>5.1)。

结果

分析了2045例患者的数据。处于缓解期(DAS)的患者在5年内HAQ无进展,而DAS28分类升高与1年时的HAQ以及第1年至第5年期间的HAQ进展率之间存在显著关系。在27986人年的随访期间,观察到392例中级手术和591例主要手术。与缓解期(DAS)分类相比,高度(DAS)组(OR 2.59,CI 1.49至4.52)和高中度(DAS)组(OR 1.8,CI 1.05至3.11)中级手术的累积发生率显著增加,高度(DAS)组(OR 2.48,CI 1.5至4.11)、高中度(DAS)组(OR 2.16,CI 1.32至3.52)和低中度(DAS)组(OR 2.07,CI 1.28至3.33)主要手术的累积发生率显著增加。缓解期(DAS)和低度(DAS)组之间在HAQ进展或骨科事件方面无显著差异。

结论

疾病活动度与功能不佳和长期骨科事件之间存在关联。这说明了持续中度疾病活动度远非良性后果,并支持欧洲抗风湿病联盟的治疗目标建议,以确保所有患者达到低疾病活动度或缓解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f78/5136699/1907faebf941/annrheumdis-2015-208669f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f78/5136699/2fb2f0bc206b/annrheumdis-2015-208669f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f78/5136699/31a2e25b6cfb/annrheumdis-2015-208669f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f78/5136699/e8fc9aa90819/annrheumdis-2015-208669f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f78/5136699/1907faebf941/annrheumdis-2015-208669f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f78/5136699/2fb2f0bc206b/annrheumdis-2015-208669f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f78/5136699/31a2e25b6cfb/annrheumdis-2015-208669f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f78/5136699/e8fc9aa90819/annrheumdis-2015-208669f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f78/5136699/1907faebf941/annrheumdis-2015-208669f04.jpg

相似文献

1
Association between rheumatoid arthritis disease activity, progression of functional limitation and long-term risk of orthopaedic surgery: combined analysis of two prospective cohorts supports EULAR treat to target DAS thresholds.类风湿关节炎疾病活动度、功能受限进展与骨科手术长期风险之间的关联:两项前瞻性队列的联合分析支持欧洲抗风湿病联盟(EULAR)的治疗达标疾病活动度评分(DAS)阈值。
Ann Rheum Dis. 2016 Dec;75(12):2080-2086. doi: 10.1136/annrheumdis-2015-208669. Epub 2016 Mar 15.
2
Predictors of and outcomes following orthopaedic joint surgery in patients with early rheumatoid arthritis followed for 20 years.对早期类风湿性关节炎患者进行20年随访的骨科关节手术后的预测因素及结果
Rheumatology (Oxford). 2017 Sep 1;56(9):1510-1517. doi: 10.1093/rheumatology/kex172.
3
In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study.在早期关节炎患者中,基线时的高 HAQ 和三个月时的 DAS28 预测两年时的结局不理想:一项回顾性队列研究。
Clin Exp Rheumatol. 2018 Sep-Oct;36(5):806-813. Epub 2018 Feb 28.
4
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.生物制剂或托法替布用于生物制剂治疗类风湿关节炎失败的患者:一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2017 Mar 10;3(3):CD012591. doi: 10.1002/14651858.CD012591.
5
Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.类风湿关节炎的病程是否正变得更轻微?1985年以来早期类风湿关节炎起始队列中的时间趋势。
Arthritis Rheum. 2005 Sep;52(9):2616-24. doi: 10.1002/art.21259.
6
Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study.早期类风湿关节炎患者随访期间缓解、身体功能正常化及工作状况变化的预测因素:一项观察性研究
Scand J Rheumatol. 2009 May-Jun;38(3):166-72. doi: 10.1080/03009740802484846.
7
Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?类风湿关节炎疾病活动评分对治疗的最佳反应:疾病活动评分(DAS28)降低>1.2是否足够?
Arthritis Res Ther. 2016 Jun 16;18(1):142. doi: 10.1186/s13075-016-1028-8.
8
Has the severity of rheumatoid arthritis at presentation diminished over time?类风湿关节炎初发时的严重程度会随时间减轻吗?
J Rheumatol. 2014 Aug;41(8):1590-9. doi: 10.3899/jrheum.131136. Epub 2014 Jul 1.
9
Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network.缓解与低疾病活动度:早期类风湿关节炎研究和网络中的功能、生活质量和结构结局。
Rheumatology (Oxford). 2020 Jun 1;59(6):1272-1280. doi: 10.1093/rheumatology/kez461.
10
Use of rheumatoid arthritis impact of disease (RAID) in routine care; identification of DAS28 remission and unmet patient-reported outcomes.在常规护理中使用类风湿关节炎疾病影响(RAID);确定DAS28缓解情况及未满足的患者报告结局。
Rheumatol Adv Pract. 2020 Apr 27;4(2):rkaa013. doi: 10.1093/rap/rkaa013. eCollection 2020.

引用本文的文献

1
First fracture in rheumatoid arthritis: analysis by fracture site, gender, age, and comorbidities.类风湿关节炎的首次骨折:按骨折部位、性别、年龄和合并症进行分析。
Osteoporos Int. 2025 Jan;36(1):113-121. doi: 10.1007/s00198-024-07311-1. Epub 2024 Nov 12.
2
Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate.非戈替尼治疗中度活动性类风湿关节炎且对甲氨蝶呤反应不足患者的疗效和安全性。
Rheumatology (Oxford). 2025 Apr 1;64(4):1661-1671. doi: 10.1093/rheumatology/keae486.
3
Rational approach to the prescription of anti-rheumatic drugs in rheumatoid arthritis: a product leaflet-based strategy in Italy.

本文引用的文献

1
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.类风湿关节炎达标治疗:国际特别工作组2014年推荐意见更新
Ann Rheum Dis. 2016 Jan;75(1):3-15. doi: 10.1136/annrheumdis-2015-207524. Epub 2015 May 12.
2
Hand and foot surgery rates in rheumatoid arthritis have declined from 1986 to 2011, but large-joint replacement rates remain unchanged: results from two UK inception cohorts.类风湿关节炎患者的手和足外科手术率从 1986 年到 2011 年有所下降,但大关节置换率保持不变:来自两个英国起始队列的结果。
Arthritis Rheumatol. 2014 May;66(5):1081-9. doi: 10.1002/art.38344.
3
Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
理性应用抗风湿药物治疗类风湿关节炎:意大利基于药品说明书的策略。
Front Immunol. 2024 Jun 24;15:1398314. doi: 10.3389/fimmu.2024.1398314. eCollection 2024.
4
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression.中度/重度系统性红斑狼疮的务实目标及其对临床护理和试验设计的意义:持续达到疾病活动反应指数(DORIS)或低疾病活动状态(LLDAS)至少6个月就足够了,而持续达到至少24个月可确保无损伤进展的高特异性。
Ann Rheum Dis. 2024 Mar 12;83(4):464-474. doi: 10.1136/ard-2023-224919.
5
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease.优化生物性抗 TNF-α 制剂在中度活跃性类风湿关节炎患者中的应用途径。
BMC Med. 2023 Feb 14;21(1):55. doi: 10.1186/s12916-023-02746-5.
6
Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis.使用推导得出的28个关节疾病活动评分患者报告部分(DAS28-P)指数,作为早期类风湿关节炎中对改善病情抗风湿药物治疗反应的鉴别指标。
BMC Rheumatol. 2022 Nov 15;6(1):67. doi: 10.1186/s41927-022-00299-3.
7
Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in Rheumatoid Arthritis Patients in Greece: Analysis of the Greek Cohort of SENSE study.希腊类风湿关节炎患者的治疗满意度、患者偏好及疾病控制欠佳的影响:希腊SENSE研究队列分析
Mediterr J Rheumatol. 2022 Mar 31;33(1):14-34. doi: 10.31138/mjr.33.1.14. eCollection 2022 Mar.
8
Exploring Factors Influencing Medication Compliance in Saudi Rheumatoid Arthritis Patients: A Nationwide Cross-Sectional Survey - Results from the COPARA Study.探索影响沙特类风湿性关节炎患者药物依从性的因素:一项全国性横断面调查——COPARA研究结果
Patient Prefer Adherence. 2022 Apr 26;16:1105-1114. doi: 10.2147/PPA.S363477. eCollection 2022.
9
The role of comorbidities alongside patient and disease characteristics in long-term disease activity in RA using UK inception cohort data.利用英国初始队列数据,探讨共病以及患者和疾病特征在类风湿关节炎长期疾病活动中的作用。
Rheumatology (Oxford). 2022 Nov 2;61(11):4297-4304. doi: 10.1093/rheumatology/keac139.
10
The Aftermath of Tapering Tocilizumab After Achieving Treatment Target in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study.类风湿关节炎患者达到治疗目标后托珠单抗减量的后果:一项全国性队列研究
Front Med (Lausanne). 2022 Feb 8;9:839206. doi: 10.3389/fmed.2022.839206. eCollection 2022.
比较诊断后第一年持续存在中度疾病活动或疾病缓解的类风湿关节炎患者的长期结局:来自 ESPOIR 队列的数据。
Ann Rheum Dis. 2015 Apr;74(4):724-9. doi: 10.1136/annrheumdis-2013-204178. Epub 2014 Jan 7.
4
Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab.类风湿关节炎患者使用 TNF 抑制剂的药物生存情况:阿达木单抗、依那西普和英夫利昔单抗的比较。
Ann Rheum Dis. 2015 Feb;74(2):354-60. doi: 10.1136/annrheumdis-2013-204128. Epub 2013 Nov 27.
5
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.依那西普联合甲氨蝶呤治疗中重度类风湿关节炎患者的依那西普维持、减量或停药(PRESERVE):一项随机对照试验。
Lancet. 2013 Mar 16;381(9870):918-29. doi: 10.1016/S0140-6736(12)61811-X. Epub 2013 Jan 17.
6
Work disability rates in RA. Results from an inception cohort with 24 years follow-up.类风湿关节炎的致残率。一项具有 24 年随访的发病队列研究结果。
Rheumatology (Oxford). 2012 Feb;51(2):385-92. doi: 10.1093/rheumatology/ker401. Epub 2012 Jan 11.
7
Outcome in rheumatoid arthritis patients with continued conventional therapy for moderate disease activity--the early RA network (ERAN).中重度疾病活动的类风湿关节炎患者继续常规治疗的结局——早期 RA 网络(ERAN)。
Rheumatology (Oxford). 2011 May;50(5):926-31. doi: 10.1093/rheumatology/keq406. Epub 2010 Dec 17.
8
An evaluation of the strengths and weaknesses of a register of newly diagnosed rheumatoid arthritis, 1986-2010.评价一个新诊断类风湿关节炎登记处的优缺点,1986-2010 年。
Rheumatology (Oxford). 2011 Jan;50(1):176-83. doi: 10.1093/rheumatology/keq318. Epub 2010 Oct 7.
9
Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity.抗TNF治疗对中度疾病活动度类风湿关节炎患者的益处。
Rheumatology (Oxford). 2009 Oct;48(10):1323-7. doi: 10.1093/rheumatology/kep242. Epub 2009 Aug 25.
10
Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.类风湿关节炎中抗肿瘤坏死因子治疗起始指南:欧洲各地的异同
Ann Rheum Dis. 2009 Apr;68(4):456-9. doi: 10.1136/ard.2008.100362.